Zydus gets US nod for schizophrenia generic medicineZydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are...
10 Oct, 2024, 11.22 PM IST
Alembic Pharma gets USFDA nod for generic drug used to treat schizophreniaAlembic Pharmaceuticals has received final approval from the USFDA for its generic version of Paliperidone extended-release tablets, used t...
27 Sep, 2024, 04.01 PM IST
Alembic Pharma gets USFDA nod to market generic antidepressant drugThe company's product is therapeutically equivalent to Otsuka Pharmaceutical Co's reference listed drug product Rexulti tablets, it added. ...
09 Mar, 2023, 02.16 PM IST
Lupin gets tentative nod from USFDA to market generic Brexpiprazole tabletsThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Brexpiprazole tab...
06 Oct, 2021, 07.07 PM IST
Zydus Cadila gets USFDA nod to market generic drugThe company has received approval from the US Food and Drug Administration (USFDA) to market in the US its generic version in strengths of ...
29 May, 2021, 03.51 PM IST
Unichem Laboratories surged 4% as company gets USFDA nod for generic Quetiapine FumarateReacting to the development, the scrip gained 4.5 per cent to hit a high of Rs 241.40 on the BSE.
10 Mar, 2016, 10.32 AM IST
Unichem Lab gets USFDA nod for schizophrenia tabletsUnichem Laboratories has received approval from the USFDA for its generic Quetiapine Fumarate tablets used for treatment of schizophrenia a...
09 Mar, 2016, 05.55 PM IST
Jubilant Life surges nearly 10% after approval for key drugThe company got approval from US drug regulators for a generic version of AstraZeneca's Seroquel drug, used for the treatment of schizophre...
29 Nov, 2013, 05.02 PM IST
Jubilant receives FDA approval for antipsychotic drugJubilant Life Sciences Ltd today said it has received approval from the US health regulator to market generic version AstraZeneca's Seroque...
28 Nov, 2013, 06.09 PM IST
- Jubilant Life's four medicines get USFDA approval
Jubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.
20 Sep, 2012, 06.32 PM IST
Wockhardt gets tentative USFDA nod for anti-psychotic drugPharmaceutical firm Wockhardt today said it has received tentative approval from US health regulator for its generic version of anti-psycho...
22 Aug, 2012, 04.34 PM IST
- Lupin, Dr Reddy's, Sun Pharma get USFDA nod for mental disorder drug
Three drug majors, Lupin, Dr Reddy's, Sun Pharma have got approvals from the US health regulator to sell generic quetiapine fumarate tablet...
28 Mar, 2012, 01.59 PM IST
- Sun Pharma gets USFDA nod for generic schizophrenia tablets
Sun Pharmaceutical Industries said it has received approval from the US health regulator for its generic Zyprexa Zydis tablets in the Ameri...
29 Feb, 2012, 07.54 PM IST
- Ranbaxy Laboratories launches generic Olanzapine tablets in Spain
Ranbaxy has received necessary regulatory approvals from the Spanish health authorities to manufacture and market Olanzapine in Spain.
25 Apr, 2011, 04.48 PM IST
- Pfizer shifts focus to cancer and biotech drugs
Pfizer Inc. is shifting its research focus to diseases that have high potential for big profits and for treatment improvements, such as can...
01 Oct, 2008, 12.34 AM IST
- Ranbaxy got USFDA nod for Risperdal
The country's largest drugmaker Ranbaxy Laboratories received the US food and drug administration (USFDA) nod to sell generic version of Ri...
04 Mar, 2008, 06.43 PM IST
- Pfizer Q3 profit doubles to $3.4bn
Pfizer on Thursday said third-quarter earnings doubled from the year-ago quarter when it took a big merger-related charge, helped by strong...
21 Oct, 2006, 12.45 AM IST